Kouji Azuma
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Clinical Outcomes of First-Line Pembrolizumab Monotherapy in Advanced NSCLC With PD-L1 Tumor Proportion Score of 1% to 49%: A Retrospective Multicenter Study.
Journal: JTO clinical and research reports
Published: August 18, 2025
Long-term survival comparison of first-line pembrolizumab versus pembrolizumab plus chemotherapy for patients with advanced non-small cell lung cancer: A multicenter propensity-matched cohort study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 12, 2025
Metachronous Mediastinal Cancers of Unknown Primary: A Case of Sequential Squamous Cell Carcinoma and Adenocarcinoma in Thoracic Lymph Nodes.
Journal: Cureus
Published: June 21, 2025
A Multicenter, Retrospective, Real-World Study of Atezolizumab Plus Chemotherapy and Pembrolizumab Plus Chemotherapy for Older Patients With NSCLC.
Journal: JTO clinical and research reports
Published: May 17, 2025
Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report.
Journal: Medicine
Published: October 21, 2020
Opioids impair nivolumab outcomes: a retrospective propensity score analysis in non-small-cell lung cancer.
Journal: BMJ supportive & palliative care
Published: June 03, 2020
A rare cause of pneumatosis intestinalis: Intestinal amyloidosis reactive to pulmonary Mycobacterium avium infection.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: May 26, 2020
Meaningful Symptoms of Immune Checkpoint Inhibitor Therapy-Related Gastrointestinal Adverse Events in Patients With Inflammatory Bowel Disease.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 07, 2020
Predictive factors for progression-free survival in non-small cell lung cancer patients receiving nivolumab based on performance status.
Journal: Cancer medicine
Published: September 06, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026